Johnson & Johnson pays $400m in compensation after product was linked to cancer

"Mrs Echeverria is dying from this ovarian cancer and she said to me all she wanted to do was to help other women throughout the whole country who have ovarian cancer for using Johnson and Johnson for 20 and 30 years.

"She really didn't want sympathy. She just wanted to get a message out to help these other women.

"Ovarian cancer is a rare disease, and increasing a small risk by a third still gives a small risk. So even if talc does increase the risk slightly, very few women who use talc will ever get ovarian cancer."